GARIAZZO, ELEONORA
 Distribuzione geografica
Continente #
AS - Asia 154
NA - Nord America 77
EU - Europa 59
SA - Sud America 33
AF - Africa 5
Totale 328
Nazione #
US - Stati Uniti d'America 75
SG - Singapore 60
HK - Hong Kong 24
BR - Brasile 23
CN - Cina 20
VN - Vietnam 18
DE - Germania 14
KR - Corea 12
FR - Francia 10
IT - Italia 10
RU - Federazione Russa 10
AR - Argentina 5
BD - Bangladesh 5
NL - Olanda 5
GB - Regno Unito 3
IQ - Iraq 3
AT - Austria 2
IN - India 2
LB - Libano 2
SE - Svezia 2
TR - Turchia 2
AZ - Azerbaigian 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
ID - Indonesia 1
JP - Giappone 1
KE - Kenya 1
MA - Marocco 1
MN - Mongolia 1
MX - Messico 1
NI - Nicaragua 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SO - Somalia 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 328
Città #
Singapore 40
Hong Kong 24
San Jose 24
Ashburn 12
Seoul 12
Munich 9
Ho Chi Minh City 6
Lauterbourg 6
Moscow 6
Piscataway 6
Boardman 5
Hanoi 5
Beijing 4
Frankfurt am Main 4
Hefei 4
Los Angeles 3
New York 3
Santa Clara 3
Amsterdam 2
Atlanta 2
Orem 2
Stockholm 2
São Paulo 2
The Dalles 2
Amelia 1
Angra dos Reis 1
Ankara 1
Aprilia 1
Asten 1
Asunción 1
Baku 1
Bastia umbra 1
Bexley 1
Bogotá 1
Bosaso 1
Bragança Paulista 1
Bắc Ninh 1
Campo Belo 1
Campos dos Goytacazes 1
Canelones 1
Caracas 1
Casablanca 1
Catanduva 1
Chennai 1
Chicago 1
Cidreira 1
Dallas 1
Dhaka 1
Diadema 1
Falkenstein 1
Goiás 1
Guarulhos 1
Huế 1
Isidro Casanova 1
Jaguaruana 1
Jeddah 1
Konya 1
Lahore 1
Managua 1
Manchester 1
Mexico City 1
Nairobi 1
Ninh Bình 1
Patna 1
Phoenix 1
Port Said 1
Quevedo 1
Quận Bình Thạnh 1
Rembangan 1
Ribeirão Claro 1
Rio Branco 1
Rio de Janeiro 1
Rondonópolis 1
Rosario 1
San Juan 1
San Miguel de Tucumán 1
Seattle 1
Sorocaba 1
Suzano 1
São Gonçalo 1
São Raimundo Nonato 1
Tokyo 1
Tunis 1
Tuparetama 1
Turku 1
Ulan Bator 1
Uruguaiana 1
Vienna 1
Villa Regina 1
Voronezh 1
Votorantim 1
Warsaw 1
Wuhan 1
Totale 257
Nome #
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer 72
Correction: Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer (Oncology and Therapy, (2024), 12, 1, (163-171), 10.1007/s40487-023-00251-6) 65
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy 58
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020) 53
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies 46
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives 41
Totale 335
Categoria #
all - tutte 1.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 1 4 0 2 0 4 2
2024/202556 1 4 2 1 4 3 1 2 3 2 23 10
2025/2026266 17 37 20 46 34 21 30 12 29 20 0 0
Totale 335